Cornelia Meisenberg
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer.
Journal: Cancer research
Published: February 25, 2021
CHD7 and 53BP1 regulate distinct pathways for the re-ligation of DNA double-strand breaks.
Journal: Nature communications
Published: October 28, 2019
Epigenetic changes in histone acetylation underpin resistance to the topoisomerase I inhibitor irinotecan.
Journal: Nucleic acids research
Published: June 11, 2016
Clinical and cellular roles for TDP1 and TOP1 in modulating colorectal cancer response to irinotecan.
Journal: Molecular cancer therapeutics
Published: December 20, 2014
TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan.
Journal: Journal of cancer science & therapy
Published: September 19, 2014
Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.
Journal: Analytical biochemistry
Published: September 24, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026